Rocket One Inc.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing therapies for unmet medical needs. Its pipeline includes HT-001, a topical treatment for skin side effects associated with cancer drugs; HT-KIT, a candidate for mast-cell cancers and anaphylaxis; HT-ALZ for Alzheimer’s and other… From the company’s description.
In fiscal 2025, Rocket One Inc. reported a net loss of $12.47M. Operations used $9.80M in cash.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Rocket One Inc. does
In the company’s own words
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing therapies for unmet medical needs. Its pipeline includes HT-001, a topical treatment for skin side effects associated with cancer drugs; HT-KIT, a candidate for mast-cell cancers and anaphylaxis; HT-ALZ for Alzheimer’s and other neuroinflammatory diseases; BioLexa for eczema; HT-004 for asthma and allergies; and HT-VA for obesity and related conditions. The company licenses intellectual property from universities and the U.S. Department of Veterans Affairs and relies on contract manufacturers; it plans to use third parties for commercialization of any approved products. Its development programs span clinical and preclinical stages, with HT-001 in a Phase 2a trial and the other candidates at earlier stages. Hoth reports no commercial product sales, and its business is focused on research and development rather than marketed medicines. Its website is https://www.hoththerapeutics.com/.
Company details
- Sector
- Health Care
- Industry (SIC)
- Pharmaceutical Preparations
- Headquarters
- HOBOKEN, NJ
- Fiscal year end
- December
- CIK
- 1711786
- SIC
- 2834
Financial performance, year by year
Fiscal 2018–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Rocket One Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Rocket One Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Rocket One Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Rocket One Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Rocket One Inc.'s last four quarterly filings that the numbers alone won't show?”